Publication: The antigenic anatomy of SARS-CoV-2 receptor binding domain
1
Issued Date
2021-04-15
Resource Type
ISSN
10974172
00928674
00928674
Other identifier(s)
2-s2.0-85102643098
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Cell. Vol.184, No.8 (2021), 2183-2200.e22
Suggested Citation
Wanwisa Dejnirattisai, Daming Zhou, Helen M. Ginn, Helen M.E. Duyvesteyn, Piyada Supasa, James Brett Case, Yuguang Zhao, Thomas S. Walter, Alexander J. Mentzer, Chang Liu, Beibei Wang, Guido C. Paesen, Jose Slon-Campos, César López-Camacho, Natasha M. Kafai, Adam L. Bailey, Rita E. Chen, Baoling Ying, Craig Thompson, Jai Bolton, Alex Fyfe, Sunetra Gupta, Tiong Kit Tan, Javier Gilbert-Jaramillo, William James, Michael Knight, Miles W. Carroll, Donal Skelly, Christina Dold, Yanchun Peng, Robert Levin, Tao Dong, Andrew J. Pollard, Julian C. Knight, Paul Klenerman, Nigel Temperton, David R. Hall, Mark A. Williams, Neil G. Paterson, Felicity K.R. Bertram, C. Alistair Siebert, Daniel K. Clare, Andrew Howe, Julika Radecke, Yun Song, Alain R. Townsend, Kuan Ying A. Huang, Elizabeth E. Fry, Juthathip Mongkolsapaya, Michael S. Diamond, Jingshan Ren, David I. Stuart, Gavin R. Screaton The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. Vol.184, No.8 (2021), 2183-2200.e22. doi:10.1016/j.cell.2021.02.032 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/76209
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Author(s)
Wanwisa Dejnirattisai
Daming Zhou
Helen M. Ginn
Helen M.E. Duyvesteyn
Piyada Supasa
James Brett Case
Yuguang Zhao
Thomas S. Walter
Alexander J. Mentzer
Chang Liu
Beibei Wang
Guido C. Paesen
Jose Slon-Campos
César López-Camacho
Natasha M. Kafai
Adam L. Bailey
Rita E. Chen
Baoling Ying
Craig Thompson
Jai Bolton
Alex Fyfe
Sunetra Gupta
Tiong Kit Tan
Javier Gilbert-Jaramillo
William James
Michael Knight
Miles W. Carroll
Donal Skelly
Christina Dold
Yanchun Peng
Robert Levin
Tao Dong
Andrew J. Pollard
Julian C. Knight
Paul Klenerman
Nigel Temperton
David R. Hall
Mark A. Williams
Neil G. Paterson
Felicity K.R. Bertram
C. Alistair Siebert
Daniel K. Clare
Andrew Howe
Julika Radecke
Yun Song
Alain R. Townsend
Kuan Ying A. Huang
Elizabeth E. Fry
Juthathip Mongkolsapaya
Michael S. Diamond
Jingshan Ren
David I. Stuart
Gavin R. Screaton
Daming Zhou
Helen M. Ginn
Helen M.E. Duyvesteyn
Piyada Supasa
James Brett Case
Yuguang Zhao
Thomas S. Walter
Alexander J. Mentzer
Chang Liu
Beibei Wang
Guido C. Paesen
Jose Slon-Campos
César López-Camacho
Natasha M. Kafai
Adam L. Bailey
Rita E. Chen
Baoling Ying
Craig Thompson
Jai Bolton
Alex Fyfe
Sunetra Gupta
Tiong Kit Tan
Javier Gilbert-Jaramillo
William James
Michael Knight
Miles W. Carroll
Donal Skelly
Christina Dold
Yanchun Peng
Robert Levin
Tao Dong
Andrew J. Pollard
Julian C. Knight
Paul Klenerman
Nigel Temperton
David R. Hall
Mark A. Williams
Neil G. Paterson
Felicity K.R. Bertram
C. Alistair Siebert
Daniel K. Clare
Andrew Howe
Julika Radecke
Yun Song
Alain R. Townsend
Kuan Ying A. Huang
Elizabeth E. Fry
Juthathip Mongkolsapaya
Michael S. Diamond
Jingshan Ren
David I. Stuart
Gavin R. Screaton
Other Contributor(s)
NIHR Oxford Biomedical Research Centre
Oxford University Hospitals NHS Foundation Trust
Public Health England
Diamond Light Source
Chang Gung University College of Medicine
Chang Gung Memorial Hospital
Worthing Hospital
University of Oxford
Washington University School of Medicine in St. Louis
Sir William Dunn School of Pathology
Faculty of Medicine Siriraj Hospital, Mahidol University
University of Kent
Nuffield Department of Medicine
University of Oxford Medical Sciences Division
Instruct-ERIC
Oxford University Hospitals NHS Foundation Trust
Public Health England
Diamond Light Source
Chang Gung University College of Medicine
Chang Gung Memorial Hospital
Worthing Hospital
University of Oxford
Washington University School of Medicine in St. Louis
Sir William Dunn School of Pathology
Faculty of Medicine Siriraj Hospital, Mahidol University
University of Kent
Nuffield Department of Medicine
University of Oxford Medical Sciences Division
Instruct-ERIC
Abstract
Antibodies are crucial to immune protection against SARS-CoV-2, with some in emergency use as therapeutics. Here, we identify 377 human monoclonal antibodies (mAbs) recognizing the virus spike and focus mainly on 80 that bind the receptor binding domain (RBD). We devise a competition data-driven method to map RBD binding sites. We find that although antibody binding sites are widely dispersed, neutralizing antibody binding is focused, with nearly all highly inhibitory mAbs (IC50 < 0.1 μg/mL) blocking receptor interaction, except for one that binds a unique epitope in the N-terminal domain. Many of these neutralizing mAbs use public V-genes and are close to germline. We dissect the structural basis of recognition for this large panel of antibodies through X-ray crystallography and cryoelectron microscopy of 19 Fab-antigen structures. We find novel binding modes for some potently inhibitory antibodies and demonstrate that strongly neutralizing mAbs protect, prophylactically or therapeutically, in animal models.
